{"abstract":"This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of a start-up exclusive patent license to practice the inventions embodied in:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2013/05/07/2013-10721.html","cfr_references":[],"citation":"78 FR 26646","comment_url":null,"comments_close_on":"2013-05-22","correction_of":null,"corrections":[],"dates":"Only written comments and/or application for a license that are received by the NIH Office of Technology Transfer on or before May 22, 2013 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2013-10721","effective_on":null,"end_page":26647,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2013/05/07/2013-10721.xml","html_url":"https://www.federalregister.gov/documents/2013/05/07/2013-10721/prospective-grant-of-start-up-exclusive-license-1-catalytic-domains-of-beta-14-galactosyltransferase","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2013-10721?publication_date=2013-05-07","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2013-05-07/2013-10721/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":74,"last_updated":"2026-08-23 20:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2013-05-07/pdf/2013-10721.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2013-10721.pdf?1367844912","publication_date":"2013-05-07","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2013/05/07/2013-10721.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NIH_FRDOC_0001","supporting_documents_count":0,"docket_id":"NIH_FRDOC_0001","regulation_id_number":null,"title":"Recently Posted NIH Rules and Notices.","checked_regulationsdotgov_at":"2013-05-27T06:00:17Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":26646,"subtype":null,"title":"Prospective Grant of Start-Up Exclusive License: 1. Catalytic Domains of Beta (1,4)-Galactosyltransferase I Having Altered Donor and Acceptor Specificities Domains, That Promote in Vitro Protein Folding and Methods for Their Use; 2. Targeted Delivery System for Bioactive Agents","toc_doc":"Catalytic Domains of Beta (1,4)Galactosyltransferase I, etc., and Targeted Delivery System for Bioactive Agents","toc_subject":"Start-Up Exclusive Licenses:","topics":[],"type":"Notice","volume":78}